The Sulfatase Pathway for Estrogen Formation: Targets for the Treatment and Diagnosis of Hormone-Associated Tumors
Open Access
- 13 February 2013
- journal article
- review article
- Published by Hindawi Limited in Journal of Drug Delivery
- Vol. 2013, 1-13
Abstract
The extragonadal synthesis of biological active steroid hormones from their inactive precursors in target tissues is named “intracrinology.” Of particular importance for the progression of estrogen-dependent cancers is the in situ formation of the biological most active estrogen, 17beta-estradiol (E2). In cancer cells, conversion of inactive steroid hormone precursors to E2 is accomplished from inactive, sulfated estrogens in the “sulfatase pathway” and from androgens in the “aromatase pathway.” Here, we provide an overview about expression and function of enzymes of the “sulfatase pathway,” particularly steroid sulfatase (STS) that activates estrogens and estrogen sulfotransferase (SULT1E1) that converts active estrone (E1) and other estrogens to their inactive sulfates. High expression of STS and low expression of SULT1E1 will increase levels of active estrogens in malignant tumor cells leading to the stimulation of cell proliferation and cancer progression. Therefore, blocking the “sulfatase pathway” by STS inhibitors may offer an attractive strategy to reduce levels of active estrogens. STS inhibitors either applied in combination with aromatase inhibitors or as novel, dual aromatase-steroid sulfatase inhibiting drugs are currently under investigation. Furthermore, STS inhibitors are also suitable as enzyme–based cancer imaging agents applied in the biomedical imaging technique positron emission tomography (PET) for cancer diagnosis.Keywords
Funding Information
- FP-6 STREP (OVCAD 2005-018698)
This publication has 108 references indexed in Scilit:
- OATPs, OATs and OCTs: the organic anion and cation transporters of theSLCOandSLC22Agene superfamiliesBritish Journal of Pharmacology, 2012
- Liganded pregnane X receptor represses the human sulfotransferase SULT1E1 promoter through disrupting its chromatin structureNucleic Acids Research, 2011
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigmHuman Pathology, 2011
- Aromatase and Dual Aromatase‐Steroid Sulfatase Inhibitors from the Letrozole and Vorozole TemplatesChemMedChem, 2011
- Regulation of specific target genes and biological responses by estrogen receptor subtype agonistsCurrent Opinion in Pharmacology, 2010
- Estrogen sulfotransferase regulates body fat and glucose homeostasis in female miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Ovarian Low-grade and High-grade Serous CarcinomaAdvances in Anatomic Pathology, 2009
- Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesisAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Potential Mechanisms of Estrogen Quinone CarcinogenesisChemical Research in Toxicology, 2007
- Origins of breast cancer subtypes and therapeutic implicationsNature Clinical Practice Oncology, 2007